NPI: 1386690956 · LEXINGTON, MS 39095 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 05/25/2006
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 05/25/2006 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 28,540 | $576K |
| 2019 | 29,547 | $554K |
| 2020 | 26,525 | $430K |
| 2021 | 18,509 | $274K |
| 2022 | 13,458 | $308K |
| 2023 | 6,873 | $412K |
| 2024 | 5,570 | $339K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 41,819 | 3,756 | $2.09M |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 38,463 | 2,368 | $465K |
| J0604 | Cinacalcet, oral, 1 mg, (for esrd on dialysis) | 706 | 387 | $138K |
| 83970 | 2,172 | 1,943 | $61K | |
| A4657 | Syringe, with or without needle, each | 6,445 | 2,845 | $39K |
| J1756 | Injection, iron sucrose, 1 mg | 7,263 | 1,867 | $33K |
| 82728 | 1,556 | 1,437 | $17K | |
| J1270 | Injection, doxercalciferol, 1 mcg | 21,407 | 2,043 | $15K |
| 83550 | 1,380 | 1,306 | $11K | |
| 83540 | 1,596 | 1,464 | $8K | |
| 85041 | 2,041 | 1,879 | $4K | |
| 85048 | 2,045 | 1,881 | $3K | |
| 90674 | 114 | 111 | $2K | |
| 90662 | 56 | 53 | $2K | |
| 85045 | 440 | 404 | $1K | |
| 82746 | 61 | 60 | $902.40 | |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 615 | 321 | $0.00 |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 692 | 471 | $0.00 |
| G0008 | Administration of influenza virus vaccine | 151 | 146 | $0.00 |